Search results
Results from the WOW.Com Content Network
Lilly's donanemab was declined accelerated approval by the FDA in January 2023, and on March 8, the agency said it would hold a meeting of its advisers to discuss the drug, further delaying its ...
The drug, donanemab, was developed by pharmaceutical company Eli Lilly and is marketed under the name Kinusla. It was approved on July 2 and is the third infusion-based drug to slow symptoms, said ...
Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [1] [2] Donanemab was developed by Eli Lilly and Company. [3] [4] The most common side effects include amyloid-related imaging abnormalities and headache. [2] Donanemab was approved for medical use in the United States in July 2024.
AccuWeather, which for many years had distributed and continues to distribute its forecast content to participating broadcast television stations around the United States, launched its first 24-hour television venture in 2007, with the launch of The Local AccuWeather Channel, a network distributed via the digital subchannels of various commercial (and in one case, non-commercial) stations ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.
The Board of Trustees of the Pennsylvania State University: Business news WPSN: 1590 AM: Honesdale: Bold Gold Media Group, L.P. News: WPSU: 91.5 FM: State College: The Pennsylvania State University: Public radio: WPSX: 90.1 FM: Kane: The Pennsylvania State University: Public radio: WPTS-FM: 92.1 FM: Pittsburgh: University of Pittsburgh ...
Get the latest news, politics, sports, and weather updates on AOL.com.
This material may not be published, broadcast, rewritten, or redistributed. For the latest news, weather, sports, and streaming video, head to The Hill. Show comments